Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
KT.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JC.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
JC.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.334EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.334EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.359EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.359EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CK.2.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CK.2.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EE.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
EE.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DB.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
DB.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BW.1.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BW.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.22EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.1.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.6EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BE.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBC.1.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
XBC.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GC.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GC.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.40EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.40EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.32EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.32EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.65EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.1.65EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.2.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CV.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
CV.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBKEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBKEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.14.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.14.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBK.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBK.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EF.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
EF.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.79EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.1.79EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.14EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FD.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FD.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.7EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used